SEC 13F Intelligence

Mai Capital Management / LLY

Mai Capital Management’s Eli Lilly & Co Position

Does Mai Capital Management own Eli Lilly & Co (LLY)? Yes — 96.1K shares worth $88M (+0.50% of its 13F portfolio) as of Q1 2026, up from 91.3K shares the prior filed quarter.

Position Value
$88M
Q1 2026
Shares
96.1K
% of Portfolio
+0.50%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $701,000Q4 ’18Q1 ’19: $728,000Q2 ’19: $498,000Q3 ’19: $520,000Q4 ’19: $1MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $20MQ4 ’20Q1 ’21: $23MQ2 ’21: $24MQ3 ’21: $25MQ4 ’21: $31MQ4 ’21Q1 ’22: $32MQ2 ’22: $38MQ3 ’22: $36MQ4 ’22: $37MQ4 ’22Q1 ’23: $32MQ2 ’23: $44MQ3 ’23: $49MQ4 ’23: $55MQ4 ’23Q1 ’24: $77MQ2 ’24: $93MQ3 ’24: $88MQ4 ’24: $84MQ4 ’24Q1 ’25: $90MQ2 ’25: $64MQ3 ’25: $65MQ4 ’25: $98MQ4 ’25Q1 ’26: $88Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202696.1K$88M+0.50%
Q4 202591.3K$98M+0.56%
Q3 202584.9K$65M+0.40%
Q2 202582.5K$64M+0.44%
Q1 2025109.6K$90M+0.68%
Q4 2024108.7K$84M+0.62%
Q3 202499.7K$88M+0.84%
Q2 2024102.4K$93M+0.91%
Q1 202499.1K$77M+0.80%
Q4 202393.6K$55M+0.72%
Q3 202391.5K$49M+0.73%
Q2 202393.1K$44M+0.64%
Q1 202393.0K$32M+0.50%
Q4 2022101.0K$37M+0.62%
Q3 2022112.2K$36M+0.68%
Q2 2022117.7K$38M+0.73%
Q1 2022113.5K$32M+0.55%
Q4 2021113.0K$31M+0.50%
Q3 2021107.9K$25M+0.48%
Q2 2021106.1K$24M+0.48%
Q1 2021121.0K$23M+0.51%
Q4 2020117.5K$20M+0.50%
Q3 202011.0K$2M+0.05%
Q2 202011.1K$2M+0.06%
Q1 202011.3K$2M+0.06%
Q4 20198.6K$1M+0.04%
Q3 20194.7K$520,000+0.02%
Q2 20194.5K$498,000+0.02%
Q1 20195.6K$728,000+0.04%
Q4 20186.1K$701,000+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mai Capital Management’s full portfolio or all institutional holders of LLY.